AssetMark Inc’s Impax Laboratories, Inc. IPXL Stock Holding History

AssetMark Inc’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,827	Closed	-$36K	–	1512
2018 Q1	$36K	Buy	1,827 +97	+6%	+$1.9K	﹤0.01%	819
2017 Q4	$29K	Buy	1,730 +928	+116%	+$17K	﹤0.01%	934
2017 Q3	$16K	Hold	802	–	–	﹤0.01%	972
2017 Q2	$13K	Hold	802	–	–	﹤0.01%	995
2017 Q1	$10K	Hold	802	–	–	﹤0.01%	982
2016 Q4	$11K	Hold	802	–	–	﹤0.01%	967
2016 Q3	$19K	Sell	802 -8	-1%	-$215	﹤0.01%	881
2016 Q2	$23K	Buy	810 +165	+26%	+$5.38K	﹤0.01%	818
2016 Q1	$21K	Buy	+645	New	+$22.7K	﹤0.01%	751

AssetMark Inc's IPXL Position: Q2 2018 in Review

AssetMark Inc sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,827 shares — an estimated $36K sold.

AssetMark Inc first reported a position in IPXL in Q1 2016 and held it in 9 quarters. The position peaked at $36K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

AssetMark Inc reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
AssetMark Inc sold 1,827 Impax Laboratories, Inc. shares in Q2 2018, an estimated $36K.
AssetMark Inc first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 9 quarters.
AssetMark Inc's Impax Laboratories, Inc. position peaked at $36K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on AssetMark Inc's 13F filing for Q2 2018, filed 1 Aug 2018.